BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6095503)

  • 1. [Changes in the creatine kinase activity in the rat heart and skeletal muscles during myorelaxation with tubocurarine, arduan and myorelaxin].
    Mozgovaia EN; Krapivina OV
    Ukr Biokhim Zh (1978); 1984; 56(5):555-8. PubMed ID: 6095503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between pipecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1987 Nov; 43(3):308-12. PubMed ID: 2832912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tactics of Arduan administration].
    Darbinian TM; Sud'in VI; Lagutina AI
    Anesteziol Reanimatol; 1982; (4):49-53. PubMed ID: 6291434
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study with Arduan and Alloferin.
    Takács G
    Ther Hung; 1984; 32(3):119-22. PubMed ID: 6100829
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adenine nucleotide and creatine phosphate levels in rat skeletal muscles and myocardium in myorelaxation].
    Krapivina OV
    Ukr Biokhim Zh (1978); 1985; 57(4):70-2. PubMed ID: 4035798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of the steroid muscle relaxant arduan in surgical interventions on the musculoskeletal system].
    Pashchuk AIu; Tiutiunnik IF; Zgola IA
    Ortop Travmatol Protez; 1984 Dec; (12):20-2. PubMed ID: 6098888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On some properties of a new steroid curare-like compound pipecurium bromide.
    Alyautdin RN; Buyanov VV; Fisenko VP; Lemina EJ; Muratov VK; Samoilov DN; Shorr VA
    Arzneimittelforschung; 1980; 30(2a):355-7. PubMed ID: 6248077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)].
    Tuba Z; Mahó S
    Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical, electromyographic and electromechanographic studies of the nondepolarizing muscle relaxant pipecurium bromide (Arduan)].
    Stoianov E; Shtŭrbova M; Marinova M
    Khirurgiia (Sofiia); 1988; 41(5):35-7. PubMed ID: 2851068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E; Bíró K
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with Arduan in anaesthesiology.
    Kovács L
    Ther Hung; 1984; 32(2):65-8. PubMed ID: 6100821
    [No Abstract]   [Full Text] [Related]  

  • 14. Oto-rhino-laryngological interventions performed in arduan relaxation.
    Zelen B
    Ther Hung; 1985; 33(4):211-3. PubMed ID: 3020731
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations made during operations performed under Arduan relaxation.
    Horváth I; Illés T
    Ther Hung; 1984; 32(1):13-5. PubMed ID: 6100828
    [No Abstract]   [Full Text] [Related]  

  • 16. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia.
    Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL
    J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pipecurium bromide (Arduan)--new steroid non-depolarizing muscle relaxant.
    Kobielski J; Wysocki M; Orlicz P; Trzaski M; Gajewski K
    Ther Hung; 1986; 34(1):45-9. PubMed ID: 2833823
    [No Abstract]   [Full Text] [Related]  

  • 18. Arduan muscle relaxation prolonged with norcuron.
    Fister T
    Ther Hung; 1991; 39(3):125-7. PubMed ID: 1687841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of xanthine oxidase activity in the brain tissue after administration of dalargin during myoplegia].
    Korotkina RN; Shloznikov BM; Donich SG; Grebenchikov OA; Sitnikov AV; Karelin AA
    Biull Eksp Biol Med; 1990 Feb; 109(2):145-6. PubMed ID: 2159814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antinociceptive properties of dalargin as an agent of anesthesiologic protection].
    Shloznikov BM; Donich SG; Grebenchikova OA; Makhmutov RF; Likhvantsev VV; Kuznetsov AIu; Peretrukin AI; Fomchenkov EP
    Biull Eksp Biol Med; 1990 Mar; 109(3):272-5. PubMed ID: 2163692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.